Biogen (BIIB) Dividends Paid - Common (2009 - 2020)
Biogen (BIIB) posted quarterly Dividends Paid - Common of $100000.0 for Q4 2020, down 97.67% year-over-year from $4.3 million in Q1 2020, and down 99.86% on a QoQ basis from $70.9 million in Q3 2020.
Biogen (BIIB) Dividends Paid - Common (2009 - 2020) Analysis & Trends
Biogen (BIIB) has reported Dividends Paid - Common for 8 consecutive years, with $100000.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Dividends Paid - Common fell 97.67% year-over-year to $100000.0; the TTM figure through Sep 2021 stood at $75.3 million (up 96.61% YoY), while the FY2020 annual figure was $71.0 million, changed N/A from the prior year.
- Dividends Paid - Common came in at $100000.0 for Q4 2020 at Biogen, down from $70.9 million in the prior quarter.
- The five-year high for Dividends Paid - Common was $302.7 million in Q1 2017, with the low at -$302.7 million in Q3 2017.
- Average Dividends Paid - Common over 4 years is $24.5 million, with a median of $4.3 million recorded in 2019.
- Across the five-year window, Dividends Paid - Common plunged 127.52% in 2018 and jumped 111.65% in 2019, its largest moves.
- Year by year, Dividends Paid - Common stood at $134.1 million in 2017, then plunged by 127.52% to -$36.9 million in 2018, then jumped by 111.65% to $4.3 million in 2019, then sank by 97.67% to $100000.0 in 2020.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $100000.0, $70.9 million, and $4.3 million for Q4 2020, Q3 2020, and Q4 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Sep 30, 2020 | 70.90 Mn |
| Sep 30, 2020 | 70.90 Mn |
| Dec 31, 2019 | 4.30 Mn |
| Dec 31, 2019 | 4.30 Mn |
| Dec 31, 2018 | -36.90 Mn |
| Dec 31, 2018 | -36.90 Mn |
| Sep 30, 2018 | -2.00 Mn |
| Sep 30, 2018 | -2.00 Mn |
| Jun 30, 2018 | 50.00 Mn |
| Jun 30, 2018 | 50.00 Mn |
| Dec 31, 2017 | 134.10 Mn |
| Dec 31, 2017 | 134.10 Mn |
| Sep 30, 2017 | -302.70 Mn |
| Sep 30, 2017 | -302.70 Mn |
| Mar 31, 2017 | 302.70 Mn |
| Mar 31, 2017 | 302.70 Mn |
| Sep 30, 2015 | 60.00 Mn |
| Sep 30, 2015 | 60.00 Mn |